Papers
1
Total Citations
23
H-Index
1
About
Ken Asada is a pioneering researcher at the intersection of epigenomics and clinical pathology, best known for developing high-throughput methods to analyze chromatin from formalin-fixed paraffin-embedded (FFPE) tissues—a notoriously challenging but clinically abundant sample type. His landmark 2021 study, “Genome-Wide Chromatin Analysis of FFPE Tissues Using a Dual-Arm Robot with Clinical Potential,” demonstrated for the first time that accurate transcription factor binding sites could be reliably mapped from archival FFPE specimens using an automated dual-arm robotic platform. This work, which has garnered 23 citations, bridges a critical gap between cutting-edge ChIP-seq technology and routine clinical diagnostics, enabling retrospective epigenomic studies on vast biobanks of preserved tissues. Asada’s contributions are particularly impactful for cancer research, where FFPE samples are the standard of care, opening new avenues for biomarker discovery and personalized medicine. His innovative integration of robotics with epigenomics not only enhances reproducibility but also holds transformative potential for translating molecular insights directly into clinical workflows.
Research Focus
Key Achievements
Top Papers
- 1